AGILE THERAPEUTICS INC Annual Interest Expense in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Agile Therapeutics Inc quarterly/annual Interest Expense history and growth rate from 2012 to 2023.
  • Agile Therapeutics Inc Interest Expense for the quarter ending March 31, 2024 was $185K, a 54% decline year-over-year.
  • Agile Therapeutics Inc Interest Expense for the twelve months ending March 31, 2024 was $1.2M, a 54.8% decline year-over-year.
  • Agile Therapeutics Inc annual Interest Expense for 2023 was $1.42M, a 54.7% decline from 2022.
  • Agile Therapeutics Inc annual Interest Expense for 2022 was $3.13M, a 20% decline from 2021.
  • Agile Therapeutics Inc annual Interest Expense for 2021 was $3.91M, a 25.9% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.42M -$1.71M -54.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $3.13M -$783K -20% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $3.91M +$805K +25.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-28
2020 $3.11M Jan 1, 2020 Dec 31, 2020 10-K 2023-03-23
2018 $1.12M -$802K -41.8% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $1.92M -$528K -21.6% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-20
2016 $2.45M +$369K +17.8% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-12
2015 $2.08M +$511K +32.6% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
2014 $1.57M +$53K +3.5% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-15
2013 $1.51M +$1.37M +980% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-09
2012 $140K Jan 1, 2012 Dec 31, 2012 10-K 2015-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.